Ovarian Cancer Treatment Platinum-sensitive Relapse - Cohort Study (PROSPECTYON)
NCT02163720
·
clinicaltrials.gov ↗
COMPLETED
Status
101
Enrollment
OTHER
Sponsor class
Conditions
Ovarian Cancer
Interventions
DRUG:
Yondelis®-Caelyx®
Sponsor
ARCAGY/ GINECO GROUP
Collaborators
[object Object]